Non-High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis

NASH is associated with significantly higher levels of non-HDL-C than steatosis in patients who do not take lipid-lowering agents. This low-cost biomarker could be used in noninvasive differentiation between steatosis and NASH.